Form 4: LENSAR Director Receives Equity Grant

Director Richard L. Lindstrom was granted 17,421 restricted stock units as part of the company's non-employee director compensation program.

Summary

• Director Richard L. Lindstrom acquired 17,421 restricted stock units (RSUs) on June 3, 2026.
• Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock.
• The grant is part of the company's standard non-employee director compensation program.
• Following this transaction, the director's total beneficial ownership is 263,831 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None.

Risks

• Vesting is subject to the director's continued service to the issuer through the vesting date of June 3, 2027.

Future Outlook

The RSUs vest in full on June 3, 2027, provided the director remains in service, or earlier upon specific events such as a change in control, death, or disability.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a long-term stake in company performance.

Comparison to Industry Standards

• The grant structure is consistent with standard equity-based compensation packages for independent directors in the medical device and healthcare technology sectors.

Corporate Governance

Stakeholder Impact

• Minor dilution impact to existing shareholders upon eventual settlement of RSUs.

Next Steps

• Vesting of RSUs on June 3, 2027.

Key Dates

Keywords

LENSAR, LNSR, Director Compensation, Equity Grant, Insider Ownership